Abortion advocates, and FDA’s authority as a federal agency, received a partial victory in North Carolina court this week, with a district judge ruling that some restrictions the state sought to impose on the abortion drug mifepristone are preempted by FDA’s congressional mandate. But the judge allowed other restrictions to stay in place under the logic that measures not explicitly rejected by FDA can be imposed by a state, a test that would allow the imposition of new prescribing obstacles...